Navigation Links
ATCC Supporting Zika Virus Research
Date:2/5/2016

MANASSAS, Va., Feb. 5, 2016 /PRNewswire-USNewswire/ -- ATCC, the premier global biological materials resource and standards organization, is poised to assist the medical and life science researchers that are working to address the evolving concerns around Zika Virus infection.  

Zika virus is a single-stranded RNA virus of the Flaviviridae family, genus Flavivirus, which also includes the West Nile, Dengue and Chikungunya Viruses. Zika virus is transmitted to humans primarily through the bite of an infected Aedes species mosquito. For more information on the disease, please refer to the CDC website.

The virus was first deposited into ATCC by Dr. Jordi Casals of the Rockefeller Foundation Virus Laboratory in 1953. Since that time ATCC has made the Zika virus (ATCC® VR-84™) strain MR766 available for research purposes to qualified scientists and laboratories, on a global basis, through a highly vetted process that requires them to demonstrate they have appropriate facilities and safety programs in place (in accordance with Biosafety in Microbiological and Biomedical Laboratories (BMBL) guidelines). ATCC is now working to respond to the greatly increased demand for the Zika virus in an effort to support a better understanding of its biology and to foster development of accurate and dependable diagnostic tests.

In addition to ATCC, three stains of the Zika virus are available through BEI Resources, a NIAID Biorepository established to support basic research and develop improved diagnostic tests, vaccines, and therapies.  Registration and approval is required by NIAID to obtain these viruses. www.beiresources.org

As the biomedical and scientific communities continue to respond to the public health concerns represented by the Zika Virus, ATCC will work closely with them to ensure they have the research and biological reference materials they need for their work. For additional information, please refer to the Zika Virus FAQ on our website.

About ATCC

ATCC collaborates with and supports the scientific community with industry-standard products and innovative solutions. With the world's largest and most diverse collection of human and animal cell lines, molecular genomic tools, microorganisms, biological products, and standards ATCC is a trusted biological resource for the worldwide research community. Together, the people of ATCC share in its mission to acquire, authenticate, preserve, develop, and distribute biological materials and information for the advancement of scientific knowledge. Founded in 1925, ATCC is a non-profit organization with headquarters in Manassas, VA. Discover more at www.atcc.org.

Logo - http://photos.prnewswire.com/prnh/20160112/321324LOGO

 


'/>"/>
SOURCE American Type Culture Collection
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. ActiGraph Releases API Supporting Actigraphy Data Collection
2. T2 Bio publishes data supporting diagnostic test T2Candida® in Science Translational Medicine
3. T2 Bio publishes data supporting diagnostic test T2Candida in Science Translational Medicine
4. NanoBio To Present Data At ICAAC Supporting The Development Of Safe And Effective RSV & Herpes Simplex Virus-2 Vaccines
5. CNTS Awarded $40 Million Contract Supporting U.S. Military Through Global Public Health
6. Tobira Therapeutics Highlights Data Presentations at the AASLD Annual Meeting Supporting its Phase 2b Program of Cenicriviroc for Nonalcoholic Steatohepatitis
7. Vault Nano Inc. Announces Granting of U.S. Cancer Immune Therapy Patent Supporting ImmunOncologyTM Programs and Treatment for Lung and Metastatic Cancers
8. Cryoport Launches New Logistics Service Supporting Facility Relocation of Cryogenically Frozen Sample Collections
9. Cryoport and Sanaria Expand Logistics Partnership Supporting Malaria Vaccines
10. HX360 Welcomes Strategic Affiliates -- Leading Healthcare, Investment And Health Tech Organizations -- Supporting Collaborative Approach To Innovation
11. Regulus to Present Additional Preclinical Data Supporting RG-012 as a Novel microRNA Therapeutic in Development for Alport Syndrome at ASNs Kidney Week 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2019)... ... May 21, 2019 , ... DuPont Nutrition & ... the inaugural Africa Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships and ... which is supported through a partnership with “Ethiopia Invest”, will run through May ...
(Date:5/14/2019)... ... 2019 , ... Gateway Genomics , a leading developer of prenatal and ... 5,000 square feet. , “This past year has seen exponential growth for the ... Chris Jacob. “The SneakPeek At-Home test, which is mailed directly to our customers who ...
(Date:5/4/2019)... PINE BROOK, N.J. (PRWEB) , ... May 03, ... ... visual electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response ... signs of glaucoma. , By 2050, it is estimated that 6.3 million Americans ...
(Date:5/2/2019)... ... May 02, 2019 , ... ... will present results documenting discrepancies between U.S. insurer policies for genetic testing and ... risk for hereditary breast and ovarian cancer (HBOC). , Jill S. ...
Breaking Biology Technology:
(Date:6/6/2019)... ... June 05, 2019 , ... Pelican BioThermal , ... station and service center in Mexico City, Mexico. Mexico is the second largest ... more than $1.75 billion in pharmaceutical exports since 2015. The Mexico City network ...
(Date:6/4/2019)... ... June 04, 2019 , ... Most preclinical EEG ... seizure risk signals, usually based on variations of amplitude, frequency or spike train ... diagnostic methodology due to the complexity and variability of the signal, and automation ...
(Date:5/31/2019)... ... May 30, 2019 , ... Researchers from Ambry ... documented significant differences in the prevalence of hereditary genetic mutations, also called germline ... White women. Results will be presented at the 2019 American Society of Clinical ...
Breaking Biology News(10 mins):